Responses
Therapeutics/Prevention
Randomised controlled trial
Weekly adalimumab significantly reduces the number of abscesses and inflammatory nodules in patients with moderate to severe hidradenitis suppurativa
Compose a Response to This Article
Other responses
No responses have been published for this article.